2012 Scrip Asia 100: Withered in Oz, a tale of research rejuvenation
This article was originally published in Scrip
Despite its small market size, Australia has traditionally attracted more than its fair share of international clinical trials. But business hasn’t been so good over the last few years. The number of new trials conducted in the country fell by 34% between 2007 and 2010, and yet investment in clinical trials globally continued to climb during this time.